Markets edged higher on Thursday morning following a solid push on Wednesday. ARK Invest funds bounced back on Wednesday. ARKG performed the best out of the group, with a 4.3% gain on the day, while ARKW did the worst, up 0.8%. The gains from the past year are slowly sliding away, but Cathie Wood may have something up her sleeve, as she is constantly reshuffling her ETFs to stand up to market headwinds.
ARK Invest has been the talk of Wall Street over the past couple of years, outperforming the market and solidifying its place among the big players in the investments world. Wood is the founder and head of this investment house, and many have compared her rising star to the likes of Warren Buffett.
Many traders are looking to mirror the plays of famous investors and huge brokerage firms to capitalize on the gains that the big dogs are making. Lucky for us, ARK Invest releases a list of its trades at the end of each trading day.
While some companies would require a subscription service or monetary fee to see what makes ARK Invest tick, here at 24/7 Wall St. we would rather give you the data for free. Here is a quick look at some of the major purchases that ARK Invest executed on December 15, 2021. Also check out all the ARK Invest sales that took place that same day.
The ARK Fintech Innovation ETF (NYSEARCA: ARKF) deals mainly with up-and-coming fintech stocks, as the name suggests. Some of its biggest holdings include Square, Zillow, Pinterest, PayPal and Alibaba. Net assets for the fund are currently $4.0 billion. Here is a notable purchase in this fund: NO BUYS
ARK Genomic Revolution ETF (NYSEARCA: ARKG) looks at companies across multiple industries, but the general focus is on health care and companies that are changing the game technologically in this field. The biggest holdings are Pacific Biosciences, Teladoc Health, CRISPR and Fate Therapeutics. Net assets for the fund are currently $9.7 billion. Here are some notable buys in this fund: 42,596 shares of Quantum-Si, 38,158 shares of Personalis and 71,797 shares of Fate Therapeutics.
ARK Innovation ETF (NYSEARCA: ARKK) has a particular focus on disruptive innovation across multiple industries, but primarily tech. Some of the biggest names are in this fund, including Tesla, Roku, Square, Zillow and Spotify. Net assets for this fund are currently $25.5 billion. Here are some notable purchases in this fund: 329,490 shares of UiPath, 60,000 shares of PagerDuty and 334,691 shares of Roblox.
ARK Autonomous Technology & Robotics ETF (NYSEARCA: ARKQ) is focused, unsurprisingly, on companies that are in the field of autonomous technology and robotics, specifically ones that are disruptively innovating. Big names in this fund include Tesla, Alphabet, JD.com, Baidu and Iridium. Net assets for this fund are currently $3.1 billion. Here are some notable purchases in the fund: 53,681 shares of UiPath and 110,275 shares of Blade Air Mobility.
ARK Next Generation Internet ETF (NYSEARCA: ARKW) is focused on companies that are disruptively innovating within the theme of the next generation of the internet. Some names in this fund are similar to the others, including Tesla, Square, Grayscale Bitcoin Trust, Facebook and Snap. Net assets for this fund are currently $6.4 billion. Here are some notable purchases in the fund: 94,674 shares of UiPath, 744,701 shares of Nu Holdings and 218,611 shares of Robinhood.
Ark Space Exploration & Innovation ETF (NYSEARCA: ARKX) is focused primarily on companies developing technology around spaceflight. Big names in this fund include Trimble, Kratos, Nvidia, Amazon and Iridium. Net assets for this fund are currently $63.3 million. Notable trades in the fund: 13,278 shares of AeroVironment and 68,004 shares of Mynaric.
Check out all the buys here:
| Fund | Ticker | Name | Shares |
|---|---|---|---|
| ARKG | VCYT | VERACYTE | 10,400 |
| ARKG | QSI | QUANTUM-SI | 42,596 |
| ARKG | PSNL | PERSONALIS | 38,158 |
| ARKG | NTLA | INTELLIA THERAPEUTICS | 5,058 |
| ARKG | MASS | 908 DEVICES | 1,900 |
| ARKG | FATE | FATE THERAPEUTICS | 71,797 |
| ARKG | BEAM | BEAM THERAPEUTICS | 15,000 |
| ARKG | ACCD | ACCOLADE | 50,489 |
| ARKK | PATH | UIPATH | 329,490 |
| ARKK | PD | PAGERDUTY | 60,000 |
| ARKK | RBLX | ROBLOX | 334,691 |
| ARKK | ROKU | ROKU | 85,334 |
| ARKK | SSYS | STRATASYS | 66,200 |
| ARKK | ZM | ZOOM VIDEO COMMUNICATIONS | 86,764 |
| ARKK | NTLA | INTELLIA THERAPEUTICS | 75,813 |
| ARKK | HOOD | ROBINHOOD MARKETS | 487,049 |
| ARKK | BEAM | BEAM THERAPEUTICS | 11,432 |
| ARKK | DNA | GINKGO BIOWORKS | 66,846 |
| ARKK | BLI | BERKELEY LIGHTS | 24,500 |
| ARKQ | PATH | UIPATH | 53,681 |
| ARKQ | MTLS | MATERIALISE | 9,096 |
| ARKQ | BLDE | BLADE AIR MOBILITY | 110,275 |
| ARKW | PD | PAGERDUTY | 58,500 |
| ARKW | PATH | UIPATH | 94,674 |
| ARKW | NU | NU HOLDINGS/CAYMAN ISLANDS | 744,701 |
| ARKW | ROKU | ROKU | 19,155 |
| ARKW | HOOD | ROBINHOOD MARKETS | 218,611 |
| ARKW | ZM | ZOOM VIDEO COMMUNICATIONS | 22,039 |
| ARKW | EDR | ENDEAVOR GROUP | 106,652 |
| ARKW | RBLX | ROBLOX | 77,507 |
| ARKX | AVAV | AEROVIRONMENT | 13,278 |
| ARKX | MYNA | MYNARIC | 68,004 |
Catherine Wood, the CEO and CIO of ARK Investment Management, is a minority and nonvoting shareholder of 24/7 Wall St., owner of a673b.bigscoots-temp.com.
100 Million Americans Are Missing This Crucial Retirement Tool
The thought of burdening your family with a financial disaster is most Americans’ nightmare. However, recent studies show that over 100 million Americans still don’t have proper life insurance in the event they pass away.
Life insurance can bring peace of mind – ensuring your loved ones are safeguarded against unforeseen expenses and debts. With premiums often lower than expected and a variety of plans tailored to different life stages and health conditions, securing a policy is more accessible than ever.
A quick, no-obligation quote can provide valuable insight into what’s available and what might best suit your family’s needs. Life insurance is a simple step you can take today to help secure peace of mind for your loved ones tomorrow.
Click here to learn how to get a quote in just a few minutes.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Latest from 24/7
